AKT1 and melanoma: The identification of a natural anti-inflammatory compound by inhibiting NFκB activity in K. galanga extracts represents a promising compound; ethyl p-methoxycinnamate (EPMC) is a potential candidate for the implementation of anti-melanoma agents that target the p38/AKT/NFκB pathway.